Qualigen shares surge 11.36% intraday as company pivots to AI/Web3, rebrands as AIxCrypto with Faraday Future as majority owner.

Qualigen Therapeutics (QLGN) surged 11.36% intraday following the announcement of a strategic pivot to AI and Web3, rebranding as AIxCrypto Holdings, Inc. with a new ticker symbol AIXC. The shift, approved by shareholders on November 12, 2025, includes Faraday Future becoming the majority shareholder with 55% ownership, expanding to 63% including affiliated entities. The transition involves a complete overhaul of the business model, including governance changes, a new three-year development roadmap, and a focus on decentralized AI and Web3 infrastructure. The market reacted positively to the rebranding, the influx of capital via a private placement, and the alignment with Faraday Future, signaling confidence in the company’s new strategic direction and long-term growth potential.